Testing naltrexone to prevent overdose in stimulant users
Part of Injuries & trauma, Mental health clinical trials.
This trial tests whether naltrexone, a medication that blocks the effects of opioids, can help prevent overdose in people who use stimulants like cocaine or methamphetamine. It may be a good fit if you are at risk for HIV or living with HIV, and have a stimulant use disorder or use stimulants at least 10 days per month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at risk for HIV or currently living with HIV.
- You have a stimulant use disorder or have tested positive for cocaine, amphetamine, or methamphetamine in the last 6 months and use stimulants at least 10 days per month.
- You are 18 years or older.
- You can speak English and give informed consent.
- You must not be using opioids (prescribed or non-prescribed) or have opioid use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two forms of naltrexone (a medication used for alcohol and opioid dependence) in healthy volunteers. It tests how well the body processes and tolerates a low or high-dose implant versus the standard monthly injection.
This trial tests whether a combination of buprenorphine (through your care plan) and a monthly extended-release naltrexone (XR-NTX) shot can help prevent opioid relapse. It may help people who are ready to move toward a naltrexone-based relapse-prevention treatment after detox.
This trial tests a naltrexone implant designed to help people with moderate to severe alcohol use disorder cut down on drinking. The implant slowly releases medication for several months, so you don't have to remember to take a pill every day.
This trial tests an overdose prevention approach for people who have used opioids recently. It aims to help reduce the risk of overdose by offering a structured prevention intervention.
This trial tests a medication called naltrexone to see if it can reduce the urge to hurt yourself. If you have a strong, repeated urge to self-injure, this treatment might help you feel more in control.
This Phase 2 study tests whether a long-acting naltrexone implant can help people with opioid use disorder stay away from opioid relapse. You may get the implant after safely finishing opioid withdrawal and stopping other naltrexone dosing at the right time.
Hear when a new Overdose Accidental trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.